Form 8-K - Current report:
SEC Accession No. 0000950170-24-126731
Filing Date
2024-11-14
Accepted
2024-11-14 07:07:09
Documents
13
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K caba-20241114.htm   iXBRL 8-K 43602
2 EX-99.1 caba-ex99_1.htm EX-99.1 103862
3 GRAPHIC img132663336_0.jpg GRAPHIC 6003
  Complete submission text file 0000950170-24-126731.txt   290277

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT caba-20241114.xsd EX-101.SCH 26988
15 EXTRACTED XBRL INSTANCE DOCUMENT caba-20241114_htm.xml XML 5115
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 241457141
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)